Expression and localization of the proteoglycan decorin during the progression of cholesterol induced atherosclerosis in Japanese quail: implications for interaction with collagen type I and lipoproteins

Atherosclerosis

Volumn 146, Issue 2, 1999, Pages 299-308

  Jarrold, Bradley B ^a   Bacon, Wayne L ^a   Velleman, Sandra G ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Cholesterol; Collagen; Decorin; Japanese quail; Proteoglycans

Indexed keywords

CHOLESTEROL; COLLAGEN TYPE 1; DECORIN; LIPOPROTEIN; PROTEOGLYCAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; QUAIL;

ANIMALS; AORTA; AORTIC DISEASES; ARTERIOSCLEROSIS; CHOLESTEROL; CHOLESTEROL, DIETARY; COLLAGEN; COTURNIX; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; LIPOPROTEINS; MALE; PROTEOGLYCANS; RANDOM ALLOCATION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032875605     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00154-9     Document Type: Article

References (50)

1. Radhakrishmanurthy B., Srinivasan S.R., Vijayagopal P., Berenson G.S. Arterial wall proteoglycans - biological properties related to pathogenesis of atherosclerosis. Eur Heart J. 11:1990;148-157.
2. Morton L.F., Barnes M.J. Collagen polymorphism in the normal and diseased blood vessel wall. Atherosclerosis. 42:1982;41-51.
3. Woolf N. The pathology of atherosclerosis with particular reference to the effect of hyperlipidaemia. Eur Heart J. 8:1987;3-14.
4. Williams K.J., Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 15:1995;551-557.
5. Walton K., Williams N. Histological and immunofluorescent studies on the evolution of the human atheromatous plaque. J Atheroscler Res. 8:1968;599-624.
6. Hoff H.F., Jackson R.L., Mao S.J.T., Gotto A.M. Localization of low-density-lipoproteins in atherosclerotic lesions from human normalipidemics employing a purified fluorescent-labeled antibody. Biochim Biophys Acta. 351:1974;407-415.
7. Camejo G., Acquatella H., Lalaguna F. The interactions of low density lipoproteins with arterial proteoglycans: an additional risk factor? Atherosclerosis. 36:1980;55-65.
8. Wagner W.D., Edwards I.J., St. Clair R.W., Barakat H. Low density lipoprotein interaction with artery derived proteoglycans: the influence of LDL particle size and the relationship to atherosclerosis susceptibility. Atherosclerosis. 75:1989;49-59.
9. Camejo G., Gunnar F., Rosengren B., Hurt-Camejo E., Bondjers G. Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells. J Biol Chem. 268:1993;14131-14137.
10. Anber V., Millar J.S., McConnell M., Shepherd J., Packard C.J. Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial proteoglycans. Arterioscler Thromb Vasc Biol. 17:1997;2507-2514.
11. Vijayagopal P., Srinivasan S.R., Radhakrishnamurthy B., Berenson G.S. Human monocyte-derived macrophages bind low-density-lipoprotein-proteoglycan complexes by a receptor different from the low-density-lipoprotein receptor. Biochem J. 289:1993;837-844.
12. Pentikäinen M.O., Öörni K., Lassia R., Kovanen P.T. The proteoglycan decorin links low density lipoproteins with collagen type I. J Biol Chem. 272:1997;7633-7638.
13. Vogel K.G., Paulsson M., Heinegard D. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J. 223:1984;587-597.
14. Yamaguchi Y., Mann D.M., Ruoslahti E. Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature. 346:1990;281-284.
15. De Luca A., Santra M., Baldi A., Giordano A., Iozzo R.V. Decorin-induced growth suppression is associated with up-regulation of p21, and inhibitor of cyclin-dependent kinases. J Biol Chem. 271:1996;18961-18965.
16. Velleman S.G., Bacon W., Whitmoyer R., Hosso S.J. Changes in distribution of glycosaminoglycans during the progression of cholesterol induced atherosclerosis in Japanese quail. Atherosclerosis. 137:1998;63-70.
17. Lennon D.P., Carrino D.A., Baber M.A., Caplan A.I. Generation of a monoclonal antibody against avian small dermatan sulfate proteoglycan: immunolocalization and tissue distribution of PG-II (decorin) in embryonic tissues. Matrix. 11:1991;412-427.
18. Bradford M. A rapid sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem J. 72:1976;248-254.
19. Velleman S.G. Quantifying immunoblots with a digital scanner. Biotechniques. 18:1995;1056-1058.
20. Statistical analysis system. SAS user's guide: statistics. 1985;SAS Institute, Cary, NC.
21. Shih J.C.H., Pullman E.P., Kao K.J. Genetic selection, general characterization, and histology of atherosclerosis-susceptible and -resistant Japanese quail. Atherosclerosis. 49:1983;41-53.
22. McCormick D.L., Radcliffe J.D., Mehta R.G., Thompson C.A., Moon R.C. Temporal association between arterial cholesterol deposition, thymidine incorporation into DNA, and atherosclerosis in Japanese quail fed an atherogenic diet. Atherosclerosis. 42:1982;1-13.
23. Vogel K.G., Trotter J.A. The effect of proteoglycans on the morphology of collagen fibrils formed in vitro. Collagen Rel Res. 7:1987;105-114.
24. Weber I.T., Harrison R.W., Iozzo R.V. Model structure of decorin and implications for collagen fibrillogenesis. J Biol Chem. 271:1996;31767-31770.
25. Danielson K.G., Baribault H., Holmes D.F., Graham H., Kadler K.E. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol. 136:1997;729-743.
26. Pringle G.A., Dodd C.M. Immunoelectron microscopic localization of the core protein of decorin near the d and e bands of tendon collagen fibrils by use of monoclonal antibodies. J Histochem Cytochem. 38:1990;1405-1411.
27. McCormick R.J., Thomas D.P. Collagen crosslinking in the heart: relationship to development and function. Basic Appl Myol. 8:1998;143-150.
28. Velleman S.G., Yeager J.D., Krider H., Carrino D.A., Zimmerman S.D., McCormick R.J. The avian low score normal muscle weakness alters decorin expression and collagen crosslinking. Connect Tissue Res. 34:1996;33-39.
29. Stevens R.L., Colombo M., Gonzales J.J., Hollander W., Schmid K. The glycosaminoglycans of the human artery and their changes in atherosclerosis. J Clin Invest. 58:1976;470-481.
30. Srinivasan S.R., Vijayagopal P., Everle K., Dalferes E.R., Radhakrishnamurthy B., Berenson G.S. Low density lipoprotein binding affinity of arterial wall isomeric chondroitin sulfate proteoglycans. Atherosclerosis. 72:1988;1-9.
31. Camejo G., Hurt-Camejo E., Wiklund O., Bondjers G. Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis. 139:1998;205-222.
32. Salisbury B.G., Falcone D.J., Minick C.R. Insoluble low density lipoprotein-proteoglycan complexes enhance cholesteryl ester accumulation in macrophages. Am J Pathol. 120:1985;6-11.
33. Vijayagopal P., Srinivasan S.R., Jones K.M., Radhakrishnamurthy B., Berenson G.S. Complexes of low density lipoproteins and arterial proteoglycan aggregates promote cholesteryl ester accumulation in mouse macrophages. Biochim Biophys Acta. 837:1985;251-261.
34. Hurt E., Bondjers G., Camejo G. Interaction of LDL with human arterial proteoglycans stimulate its uptake by human monocyte-derived macrophages. J Lipid Res. 31:1990;443-454.
35. Vijayagopal P., Srinivasan S.R., Radhakrishnamurhty B., Berenson G.S. Lipoprotein-proteoglycan complexes from atherosclerotic lesions promote cholesteryl ester accumulation in human monocytes/macrophages. Arterioscler Thromb. 12:1992;237-249.
36. Robbins R.A., Wagner W.D., Sawyer L.M., Caterson B. Immunolocalization of proteoglycan types in aortas of pigeons with spontaneous or diet-induced atherosclerosis. Am J Pathol. 134:1989;615-626.
37. Lin H., Wilson J.E., Roberts C.R., Horley K.J., Winters G.L., Costanzo M.R. et al. Biglycan, decorin, and versican protein expression patterns in coronary arteriopathy of human cardiac allografts: distinctness as compared to native atherosclerosis. J Heart Lung Transplant. 15:1996;1233-1247.
38. Iverius P.H. The interaction between human plasma lipoproteins and connective tissue glycosaminoglycans. J Biol Chem. 247:1971;2607-2613.
39. Hanson A.N., Bentley J.P. Quantitation of type I to type III collagen ratios in small samples of human tendon, blood vessels, and atherosclerotic plaque. Anal Biochem. 130:1983;32-40.
40. Tammi M., Seppälä P.O., Lehtonen A., Möttönen M. Connective tissue components in normal and atherosclerotic human coronary arteries. Atherosclerosis. 29:1978;191-194.
41. Wagner W.D., Salisbury B.G.J. Aortic total glycosaminoglycan and dermatan sulfate changes in atherosclerotic rhesus monkeys. Lab Invest. 39:1978;322-328.
42. Ylä-Herttuala S., Sumuvuori H., Karkola K., Möttönen M., Nikkari T. Glycosaminoglycans in normal and atherosclerotic human coronary arteries. Lab Invest. 54:1986;402-407.
43. Murata K., Yokoyama Y. Acidic glycosaminoglycans in human atherosclerotic cerebral arterial tissues. Atherosclerosis. 78:1989;69-79.
44. Murata K., Motayama T., Kotake C. Collagen types in various layers of the human aorta and their changes with the atherosclerotic process. Atherosclerosis. 60:1986;251-262.
45. Riessen R., Isner J.M., Blessing E., Loushin C., Nikol S., Wight T.N. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol. 144:1994;962-974.
46. Lin H., Tsugiyasu K., Hoshino Y., Shin-ichi T., Kobayashi I., Ryozo N. et al. Verscian, biglycan, and decorin protein expression patterns in coronary arteries: analysis of primary and restenotic lesions. Cardiovasc Pathol. 7:1998;31-37.
47. Evanko S.P., Raines E.W., Ross R., Gold L.I., Wight T.N. Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-β Am J Pathol. 152:1998;533-546.
48. Järveläinen H.T., Kinsella M.G., Wight T.N., Sandell L.J. Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture. J Biol Chem. 266:1991;23274-23281.
49. Edwards I.J., Wagner W.D., Owens R.T. Macrophage secretory products selectively stimulate dermatan sulfate proteoglycan production in cultured arterial smooth muscle cells. Am J Pathol. 136:1990;609-621.
50. Edwards I.J., Xu H., Wright M.J., Wagner W.D. Interleukin-1 upregulates decorin production by arterial smooth muscle cells. Arterioscler Thromb. 14:1994;1032-1039.